Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human, Rat, Bovine (tested or 100% immunogen sequence identity)
ICC (1:100 - 1:1000)
Western blot (1:500 - 1:3000)
Specificity and Use
SLC9A1BP / CHP antibody was raised against synthetic peptide corresponding to a region within amino acids 47 and 141 of Calcium binding protein P22 (SwissProt Q99653). Percent identity by BLAST analysis: Human, Rat, Bovine (100%).
Human SLC9A1BP / CHP
0.1 M Tris-glycine, pH 7.0, 10% glycerol, 0.01% Thimerosal
Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
CHP1 Antibody, Calcium-binding protein p22 Antibody, Calcineurin B homolog Antibody, Calcium binding protein P22 Antibody, Calcium-binding protein CHP Antibody, Calcineurin B-like protein Antibody, CHP Antibody, p22 Antibody, SLC9A1 binding protein Antibody, SLC9A1BP Antibody, Sid470p Antibody, Calcineurin homologous protein Antibody, p24 Antibody
Calcium-binding protein involved in different processes such as regulation of vesicular trafficking, plasma membrane Na+/H+ exchanger and gene transcription. Involved in the constitutive exocytic membrane traffic. Mediates the association between microtubules and membrane-bound organelles of the endoplasmic reticulum and Golgi apparatus and is also required for the targeting and fusion of transcytotic vesicles (TCV) with the plasma membrane.